GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Change In Other Working Capital

Cleo Diagnostics (ASX:COV) Change In Other Working Capital : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Change In Other Working Capital?

Cleo Diagnostics's Change In Other Working Capital for the quarter that ended in Dec. 2023 was A$0.00 Mil. It means Cleo Diagnostics's Other Working Capital stayed the same from Jun. 2023 to Dec. 2023 .

Cleo Diagnostics's Change In Other Working Capital for the fiscal year that ended in Jun. 2023 was A$0.00 Mil. It means Cleo Diagnostics's Other Working Capital stayed the same from . 20 to Jun. 2023 .

Cleo Diagnostics Change In Other Working Capital Historical Data

The historical data trend for Cleo Diagnostics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Change In Other Working Capital Chart

Cleo Diagnostics Annual Data
Trend Jun23
Change In Other Working Capital
-

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23
Change In Other Working Capital - - -

Cleo Diagnostics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleo Diagnostics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Change In Other Working Capital
Comparable Companies
ASX:CVB ASX:ADR ASX:CSX ASX:CDX ASX:OSL ASX:AT1 ASX:CMP ASX:HMD ASX:RSH ASX:RNO ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Website
https://www.cleodx.com
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines